Description
Batimastat, soluble in DMSO and insoluble in ethanol and water, inhibits MMPs, enzymes that degrade extracellular matrix components, thus having potential therapeutic applications in cancer and chronic inflammatory diseases. It targets MMP-1, MMP-2, MMP-3, MMP-7, and MMP-9.